Guide to CancerSCAN Targeted Anticancer Therapy

CancerSCAN is a cancer genome diagnosis solution for anticancer therapy that is customized to individuals, developed for the first time in Korea as a product of joint research with the clinicians at the Samsung Genome Research Center. It is based on NGS technology that accurately detects the diverse types of patient specimen mutations accurately and predicts patient prognosis through a database by selecting an optimal targeted anticancer agent and immuno-oncology most appropriate for the patient via a panel developed on the basis of several years of clinical experience.

In addition, our company has developed OncoSTATION which encompasses the entire range of processes from automated experimentation and analysis data quality management system (laboratory information management system - LIMS) to data processing, QC, mutation detection, annotation and report generation, and providing related services in association with CancerSCAN In order to supplement the environmental difficulties in NGS clinical examinations in Korea (specialized personnel and equipment, etc.).